AI-generated summary
The authors ran a randomized split-face trial in 15 Korean patients with rosacea, comparing 585-nm pulsed dye laser treatment with and without topical niacin pretreatment on opposite halves of the face. Physician assessment and patient satisfaction were higher on the niacin-pretreated side, while objective erythema improvement did not differ between sides. The authors describe niacin pretreatment as safe, with only transient erythema and edema reported.
- Participants
- 15
- Who or what was studied
- Korean patients with rosacea-associated erythema (15 completed the study, 18 recruited)
- Wavelengths
- 585 nm
- Limits stated in the abstract
- The abstract reports a small sample of 15 completers and does not describe a long-term follow-up period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Chromophore, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.